Semi-synthetic DNA shuffling of aveC leads to improved industrial scale production of doramectin by Streptomyces avermitilis
- 31 January 2005
- journal article
- Published by Elsevier in Metabolic Engineering
- Vol. 7 (1), 27-37
- https://doi.org/10.1016/j.ymben.2004.07.003
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Surveying a local fitness landscape of a protein with epistatic sites for the study of directed evolutionBiopolymers, 2002
- Metabolic engineering and directed evolution for the production of pharmaceuticalsCurrent Opinion in Biotechnology, 2000
- Doramectin — a potent novel endectocideVeterinary Parasitology, 1993
- Novel avermectins produced by mutational biosynthesis.The Journal of Antibiotics, 1991
- Branched-chain fatty acid requirement for avermectin production by a mutant of Streptomyces avermitilis lacking branched-chain 2-oxo acid dehydrogenase activity.The Journal of Antibiotics, 1991
- Further studies on the biosynthesis of the avermectinsJournal of Industrial Microbiology & Biotechnology, 1989
- Studies on the biosynthesis of avermectinsArchives of Biochemistry and Biophysics, 1989
- A comprehensive set of sequence analysis programs for the VAXNucleic Acids Research, 1984
- Biosynthetic origin of the carbon skeleton and oxygen atoms of the avermectinsJournal of the American Chemical Society, 1983
- Avermectins, New Family of Potent Anthelmintic Agents: Producing Organism and FermentationAntimicrobial Agents and Chemotherapy, 1979